Cigna Corporation Reported Better Than Expected Q3 Results
<p><a href='https://financialmodelingprep.com/financial-summary/CI'>Cigna Corporation (NYSE:CI) </a>reported its Q3 results, with EPS coming in at $5.73, which beat the consensus estimate by 9.6%, driven by Evernorth ($1.55 billion), while US Medical ($0.99 billion) was slightly ahead due in part to stronger investment income and specialty contribution, which overcame MCR pressures concentrated in the exchange Special Enrollment Period (SEP) additions.</p>
<p>The company revised its 2021 outlook, now expecting adjusted revenues of $172 billion from $170 billion prior. EPS is expected to be $20.35, raised from prior guidance of $20.20.</p>
<p>Following the quarter, analysts at Oppenheimer raised their 2021/2022 EPS estimates to $20.36/$22.43 from $20.33/ $22.23. The analysts believe the company continues to successfully navigate the pandemic.</p>

NYSE:CI